EPISODE · Apr 27, 2026 · 30 MIN
Genyro’s Adrian Woolfson on Artificial Biological Intelligence and Genome Writing
from Citeline Podcasts · host Norstella
In this In Vivo podcast, David Wild speaks with Adrian Woolfson, co-founder, president and CEO of Genyro, about how high-fidelity DNA writing and AI-driven genome design could reshape biopharma R&D, from accelerating program design and iteration speed to enabling civilizational-scale applications like DNA-based data storage and ultra-fast vaccine manufacturing. Woolfson, a physician-scientist, explains why Genyro is pursuing a licensing-led business model and which transformative applications he believes will emerge first.
What this episode covers
In this In Vivo podcast, David Wild speaks with Adrian Woolfson, co-founder, president and CEO of Genyro, about how high-fidelity DNA writing and AI-driven genome design could reshape biopharma R&D, from accelerating program design and iteration speed to enabling civilizational-scale applications like DNA-based data storage and ultra-fast vaccine manufacturing. Woolfson, a physician-scientist, explains why Genyro is pursuing a licensing-led business model and which transformative applications he believes will emerge first.
NOW PLAYING
Genyro’s Adrian Woolfson on Artificial Biological Intelligence and Genome Writing
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m